The Agência Nacional de Vigilância Sanitária (ANVISA) approved a new medication for the prevention of migraine attacks. The medication was approved for use in adults who experience at least four migraine episodes per month. The treatment now joins the available options for patients suffering from episodic and chronic migraine. The approval represents a new therapeutic alternative for those seeking to control the painful attacks that affect millions of Brazilians.
ANVISA approves new medication to prevent migraine attacks
Portal O Dia8 September 2026 at 13:49
Related articles

Science
The Order launches mental health program for nurses with consultations and SOS line
08/09/26, 19:14



